Characterization of Subjective Discomfort in Patients With Tear Dysfunction
Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Feb 10, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the feelings of discomfort or pain that patients experience due to dry eye disease (DED), a condition where the eyes don't produce enough tears or the right quality of tears. The goal is to better understand how these feelings are related to the overall health of the eye's surface and any other medical tests. This information could help improve treatments for people suffering from dry eyes.
The trial is looking for adult participants, particularly those aged 65 to 74, who have been diagnosed with or suspected to have dry eye disease. There are no specific exclusions, so if you meet the age and diagnosis criteria, you may be eligible to participate. If you join the study, you can expect to share your experiences with eye discomfort, and researchers will also conduct some clinical tests to gather more information. This research could lead to better ways to help manage dry eye symptoms in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adult patients with suspected or diagnosed DED
- Exclusion Criteria:
- • nothing
About Irccs Azienda Ospedaliero Universitaria Di Bologna
IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, , Italy
Patients applied
Trial Officials
Luigi Fontana, MD
Principal Investigator
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported